Skip to main content

Zentek Upsizes Private Placement to $2.5 Million

Tipranks - Tue Oct 21, 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Zentek ( (TSE:ZEN) ) has issued an announcement.

Zentek Ltd. has announced an increase in its non-brokered private placement to raise up to $2,500,000, with each unit priced at $1.06. The proceeds will be used for working capital and general corporate purposes. Each unit comprises one common share and two half-warrants, which can be converted into common shares at specified prices and conditions. The offering is subject to regulatory approvals and includes a hold period for the issued securities.

The most recent analyst rating on (TSE:ZEN) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Zentek stock, see the TSE:ZEN Stock Forecast page.

Spark’s Take on TSE:ZEN Stock

According to Spark, TipRanks’ AI Analyst, TSE:ZEN is a Neutral.

Zentek’s overall stock score is primarily impacted by its financial performance, which is challenged by negative profitability and cash flow issues. Technical analysis provides some support with mixed signals, but valuation metrics indicate potential overvaluation. The absence of earnings call data and corporate events means these factors do not influence the score.

To see Spark’s full report on TSE:ZEN stock, click here.

More about Zentek

Zentek Ltd. is an ISO 13485:2016 certified intellectual property technology company focused on the research, development, and commercialization of novel products. The company aims to provide its commercial partners with a competitive advantage by enhancing product performance, safety, and environmental friendliness. Zentek’s patented technology platform, ZenGUARD™, improves viral filtration efficiency in surgical masks and HVAC systems. Additionally, Zentek holds a global exclusive license for an Aptamer-based platform technology developed with McMaster University, targeting diagnostic and therapeutic markets.

YTD Price Performance: -25.53%

Average Trading Volume: 61,295

Technical Sentiment Signal: Sell

Current Market Cap: C$109.9M

For detailed information about ZEN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.